MedTrace Logo

Performance Evaluation of FullCeram Implants in Single Tooth Gaps

NCT02163395 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 44

Last updated 2023-11-22

Study results available
· View outcomes & findings →

Summary

* Straumann Monotype FullCeram implants serve as a suitable alternative for implant therapy especially in the aesthetic zone
* The survival rate of Straumann Ceramic implants should be at least 85% (max 6 implant losses out of 40 patients) after the first year

Conditions

  • Tooth Loss

Interventions

DEVICE

FullCeram implant

FullCeram implantation

Sponsors & Collaborators

  • Institut Straumann AG

    lead INDUSTRY

Principal Investigators

  • Michael Gahlert, Prof Dr Dr · Oralchirurgie T1

Study Design

Allocation
NA
Purpose
OTHER
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2011-10-31
Primary Completion
2013-09-30
Completion
2023-11-21

Countries

  • Germany

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02163395 on ClinicalTrials.gov